Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

76.23 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
37 38 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook
From DexCom, Inc.
Via Business Wire
Dexcom Appoints Teri Lawver as Chief Commercial Officer
From DexCom, Inc.
Via Business Wire
Analyst Expectations for DexCom's Future
 
Via Benzinga
10 Analysts Have This to Say About DexCom
 
Via Benzinga
Dexcom Flirts With Breakout After FDA Clears Next-Gen Diabetes Device
The company will launch its G7 in the U.S. "in the coming months." 
Via Investor's Business Daily
Is This Stock-Split Stock a Buy For 2023?
Don't buy this company's shares for its recent stock split. 
Via The Motley Fool
Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
Have $2,000 to Invest? 2 Top Stocks That Could Go Parabolic
Stocks with long-term growth potential abound even in the current market. 
Via The Motley Fool
2 Growth Stocks to Invest $1,500 in Before the End of 2022
Opportunities are abundant right now, even if share prices are down. 
Via The Motley Fool
The Best Stocks to Invest $5,000 in Right Now
Consistently investing your cash in both up and down markets can make you richer in the long run. 
Via The Motley Fool
1 Passive Income Stock to Buy Today, and 1 to Avoid for Now
Rising interest rates don't affect all passive income stocks equally. 
Via The Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
These growing businesses are just starting to see the beginning of their long-term potential. 
Via The Motley Fool
Can FDA Approval Bolster DexCom, Inc.?
Dexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value). 
Via MarketBeat
Kaival Brands ($KAVL) and KMS gear up for anticipated revenue growth by hiring former Swisher International VP of Sales
Via AB Newswire
Topics Economy
Stock Market Rally Falls On Recession Fears; Tesla Plunges On China News: Weekly Review
The stock market rally suffered significant weekly losses as recession fears mounted. Tesla stock dived on China demand concerns. 
Via Investor's Business Daily
Have $1,000? 2 Smart Stocks to Buy in a Nasdaq Bear Market
A down market doesn't mean you should hit pause on adding new stocks to your portfolio. 
Via The Motley Fool
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
From DexCom, Inc.
Via Business Wire
2 Monster Stocks to Buy Without Any Hesitation
These two top stocks are giants in their respective industries with plenty of growth runway left. 
Via The Motley Fool
The Best Stocks to Invest $20,000 in Right Now
The market is ripe with opportunity. 
Via The Motley Fool
3 Supercharged Growth Stocks to Buy for 2023
Next year could be a very important one for all three of these fast-growing businesses. 
Via The Motley Fool
Stock Market Investing Action Plan: What Part Of November Don't You Understand?
A turnabout month left the market sitting on some nice gains. The next week's data might determine whether those gains hold. 
Via Investor's Business Daily
Dexcom Leads 5 Stocks Near Buy Points
They combine strong technicals and generally sound fundamentals. 
Via Investor's Business Daily
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
Don't let the current market keep you from putting spare cash to work in great companies. 
Via The Motley Fool
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
3 No-Brainer Growth Stocks to Buy for 2023 and Beyond
No-brainer growth stocks to buy for 2023 and beyond are companies that are growing their top and bottom lines and piling up the cash. 
Via InvestorPlace
Golden Cross Appears Before DexCom Investors
If history is any guide, there may be good fortune ahead for shares of DexCom (NASDAQ:DXCM). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the... 
Via Benzinga
Got $2,000? 2 Fantastic Stocks to Buy No Matter What the Market Does Next
These stocks both have non-cyclical businesses that can drive growth in a wide variety of markets. 
Via The Motley Fool
Got $1,000? 2 Bear Market Stocks to Jump On Right Now
Regardless of what the market does next, these top stocks have a much longer growth trajectory ahead. 
Via The Motley Fool
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.